The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable excitement within the healthcare community. This novel dual GIP and GLP-1 receptor medication appears to offer impressive improvements in weight loss compared to current therapies. Preliminary clinical data have indic